A chronic dysfunctional stress response can cause stroke by stimulating platelet activation, migraine, and...

Area of Science:

• Neuroscience
• Cardiovascular Medicine
• Hematology

Background:

• A chronic dysfunctional response to stress can manifest as migraine, hypertension, and systemic platelet activation, creating a hypercoagulable state.
• This physiological triad can acutely worsen, leading to intracranial occlusion (stroke).
• The role of stress in stroke pathogenesis is complex and warrants further investigation.

Purpose of the Study:

• To propose a unifying hypothesis for the mechanism of acute intracranial occlusion.
• To explore the link between stress, migraine, hypertension, and hypercoagulable states in stroke.
• To identify potential therapeutic targets for stroke prevention.

Main Methods:

• Literature review to analyze existing data on migraine, hypertension, platelet activation, and stroke.
• Hypothesis generation based on the synthesis of physiological and neurological evidence.
• Therapeutic prediction based on the proposed mechanism.

Main Results:

• Migraine, hypertension, and platelet activation form a distinct physiological entity that can precipitate stroke.
• Elevated blood pressure and headache associated with stroke are likely pre-existing markers, not consequences of the stroke itself.
• Systemic platelet activation is identified as a crucial, previously overlooked factor linking migraine and stroke.

Conclusions:

• Migraine and hypertension serve as clinical markers for underlying platelet activation and a hypercoagulable state, increasing stroke risk.
• Overactive pacemaker cells in the dorsal raphe nucleus are hypothesized to drive migraine, hypertension, and platelet activation.
• Ethosuximide, by blocking T-type calcium channels in the dorsal raphe nucleus, is predicted to be a potential therapeutic agent for stroke prevention.